Coherus BioSciences and Mark Cuban’s Cost Plus Drug Company will shake up the Humira and Humira-referenced biosimilar space with the launch of Yusimry at a 85% discount.
Category: pharma & healthcare
Coherus BioSciences And Mark Cuban’s Drug Company Aim To Disrupt Humira-Referenced Biosimilar Space With Launch Of Yusimry At A 85% Discount
Coherus BioSciences and Mark Cuban’s Cost Plus Drug Company will shake up the Humira and Humira-referenced biosimilar space with the launch of Yusimry at a 85% discount.
Restoring The Sense Of Touch: Advances In Artificial Skin Technology
Advances in haptic skin may restore the sense of touch to those who have lost limbs or touch sensation.
Pharmaceutical Industry Ought To Justify Drug Prices On Value, Not R&D Costs
Sometimes a lot of R&D goes into only marginally effective drugs. Other times, drugs with relatively minimal amounts of R&D turn out to have a lot of value.
Adapted SynNotch, A New Generation Of Flexible And Controllable CAR T Therapies (Part 3)
This is the final installment in our series on alternate CAR T therapies—specifically synNotch cells—using universal adaptors.
How One Man’s Rare Alzheimer’s Mutation Delayed The Onset Of Disease
Researchers in Colombia have identified a genetic mutation that may protect individuals from symptoms of dementia in Alzheimer’s disease.
Does The Hepatitis D Genome Encode Proteins From Both The “Plus” And “Minus” Strands?
Hepatitis D Virus encodes two known proteins. Both are produced from genes in the “minus” strand; might the “plus” strand also encode proteins?
Does The Hepatitis D Genome Encode Proteins From Both The “Plus” And “Minus” Strands?
Hepatitis D Virus encodes two known proteins. Both are produced from genes in the “minus” strand; might the “plus” strand also encode proteins?
SynNotch, A New Generation Of Flexible And Controllable CAR T Therapies (Part 2)
In this second installment, we describe an alternate and highly customizable cell-based treatment to CAR T therapy.
Why Hasn’t The United States Eliminated Hepatitis C When Egypt Did So? Why Are The United States’ Plans To Eliminate Hepatitis C 10 Times More Expensive Per Person And Take 10 Times Longer?
In the previous story, we saw how Egypt’s 100 Million Healthy Lives program achieved country wide elimination by demonstrating the will and organization to do so, as w…
